Blogs

Science is supposed to be evidence-respecting and thereby open-minded; psychiatry is presently not. But is psychiatry really unique in this respect? Is it the only field of medicine where dogmatically held theories contrary to evidence have held sway for long periods?

Mental health agencies are mainly asking about her positions regarding “recovery” and “peers,” but here are some tougher questions for President Trump's new "mental health czar": Do you support court-ordered psychiatric drugging? Do you endorse the use of federal money for it? Why aren’t non-drug alternatives offered to Americans?

Thousands of boys and young men are lined up in courthouses around the country to sue J&J for gynecomastia caused by taking Risperdal as young children. The condition is irreversible except by surgical removal. Collectively, they have become known as the Risperdal Boys.

Scientific evidence indicates that antidepressants do not help children. In light of such high risks to the child’s wellbeing, these psychiatric chemicals are clearly doing more harm than good. What kind of society would permit this assault on its children?

Even though it is extremely unlikely that in France we would reach the kinds of percentages we see in the USA, where in some states nearly 10% of children are treated with methylphenidate or other psychostimulants not used in France, overprescription is highly probable. Why?

The new wave of psychosocial treatments is encouraging, but does not go far enough in recognizing psychosis as an attempt by the psyche to heal itself. Until psychiatrists receive training in metaphor and symbol, we will continue gluing the pieces of Humpty-Dumpty back together again.

We seldom have a chance to hear from someone who combines the perspective of a longtime psychiatric survivor and activist with that of being a psychiatrist. I disagreed with only one significant point — that a person does not have to be off all medications to show “complete recovery” from “mental illness.”

The World Hearing Voices Congress will be landing in Boston, Massachusetts in August. The Hearing Voices movement is up against a lot in this culture where there's so little tolerance for uncertainty and exploration. This movement, this event, and so many people's lives depend on all of us to carry this perspective forward.

I am participating in World Benzodiazepine Awareness Day today, and you should too, because you know somebody right now who is taking a benzodiazepine and that person might just be dealing with chronic health problems, unaware that they are result of taking the medication as prescribed.

I am still trying to reconcile what these chemicals are capable of, how the urge can morph into an action, how we maybe just don’t understand suicide all that well. For me, the suffering was so intense it was too painful to stay alive. I understand how my friends felt in their last moments.

One size fits all does not work. It is not possible to use the same tapering schedule for all patients who wish to stop with a certain drug. Therefore we had to come up with a flexible solution that was both practical and allowed doctors and patients to make the choice they deemed appropriate.

In commemoration of World Benzodiazepine Awareness Day coming on July 11th, I am providing an early first time debut at Mad in America of a new song and music video titled “Benzo Blue,” along with a brief commentary on the evolution and significance of this song.

This “Mental Health Czar” appointment is moving below the radar of many people. The US Senate should be asking some tough questions of Dr. McCance-Katz before deciding on her confirmation. Everyone should contact their Senators, now!

If we are to achieve the much-needed paradigm shift in the way we respond to human suffering, it is imperative that we unite. Given the powerful vested interests sustaining the dominant bio-medical model, a fragmented opposition will possess insufficient power to transform the system.

Establishing a comprehensive drug review map will make possible a complete assessment of the expenditures on psychiatric drugs. I predict that these expenditures are going to surprise and concern anyone responsible for managing these costs.

With reports of the horrid abuse at Oak Ridge surfacing frequently over the years, how could this travesty have continued unabated for so long? What is wrong with the “therapeutic” community that what happened here was hailed as a major advance?

Modern psychiatrists are taught that all mental disorder is biological in nature. As a result, they aren't taught psychotherapy, and when they get a complicated patient, they don't know what to do. Thus, they very quickly reach the limit of their skill set and have no option but to reach for the electrodes.

I think it is fair to say that many psychiatrists display an enormous lack of good sense and judgment. Psychiatrists are in the firm grip of a collective force field of an almost fundamentalist belief system that blinds them to the harm they unwittingly do and the human rights abuses they commit.

It now looks as if the U.S. approach to mental health is fast gaining purchase in a country that formerly boasted a great, perhaps too sophisticated (Lacan et al.) psychoanalytic tradition, but also a holistic psychosocial tradition when dealing with psychological disturbance in children.

Despite study after study after study showing that there is a simple, cheap solution to reducing aggression in many people, the message hasn’t carried through to changing policies or treatment approaches. If a drug were shown to reduce aggression with no side effects, would it be ignored?

When the neuroleptics-are-necessary-to-treat-schizophrenia myth falls, psychiatry is finished. And that is why the Goff et al paper was produced: a desperate attempt to maintain its position by a profession that is truly on the ropes. For psychiatry this is a death-struggle.

The Commission was addressed by organizations engaged with various aspects of addiction treatment. Much of the input seemed apropos, but one voice was missing. Speakers failed to include even one practicing physician or advocate for the pain patients who have been blamed for the so-called “opioid epidemic.”

We are now launching a new effort, one that has us excited about its possibilities. MIA Radio will begin airing podcasts on July 1. We will be both producing our own MIA podcasts and serving as a host for independently produced critical psychiatry podcasts.

The vast majority of the data shows that people who benefit from psychiatric drugs are statistical outliers. You got lucky. We're glad you got lucky. But your story is not the whole story. Public policy decisions shouldn't be based on "the lucky ones," they should take into account all aggregate data.

Despite everyone's best intentions, the river of psychopharmacy was making its path through the global south, with no stops anywhere within policy or practice. INTAR India 2016 became very important for the global south against this rising tide and the overmedicalization of people's psychosocial distress and disabilities.